Max Robotics — Global Service Robot Directory + US Certification

About

Christine Allen is a pioneering researcher whose work spans drug delivery, tumor biology, and the cutting-edge field of autonomous experimentation. Her foundational contributions to nanomedicine include landmark investigations into how microcirculation and interstitial fluid pressure govern liposome accumulation within solid tumors — work that has garnered over 74 citations and shed critical light on why nanoparticle-based therapies often fail to distribute uniformly within cancerous tissue, a key barrier to improving therapeutic efficacy. More recently, Allen has emerged as a leading voice in the development of self-driving laboratories (SDLs) — autonomous, AI-driven platforms that integrate robotics and high-performance computing to accelerate scientific discovery. Her "Atlas" framework, cited nearly 50 times across publications in 2023 and 2025, represents a significant architectural contribution to this rapidly evolving field. Complementing this, her 2024 paper on AI and robotics in pharmaceutical formulation has already attracted 17 citations, reflecting growing recognition that autonomous systems could fundamentally transform drug development. Allen's work uniquely bridges oncology-focused drug delivery with next-generation laboratory automation, positioning her as an innovator reshaping both how medicines are designed and how science itself is conducted.